Cargando…
The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells
Bisphosphonates are well established in the management of cancer-induced bone disease. Recent studies have indicated that these compounds have direct inhibitory effects on cultured human breast cancer cells. Nitrogen-containing bisphosphonates including zoledronic acid have been shown to induce apop...
Autores principales: | Senaratne, S G, Mansi, J L, Colston, K W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375368/ https://www.ncbi.nlm.nih.gov/pubmed/11986784 http://dx.doi.org/10.1038/sj.bjc.6600297 |
Ejemplares similares
-
The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells
por: Senaratne, S G, et al.
Publicado: (2002) -
New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
por: Denoyelle, C, et al.
Publicado: (2003) -
The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
por: Senaratne, Siddhika G, et al.
Publicado: (2002) -
Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
por: Neville-Webbe, H L, et al.
Publicado: (2010) -
Bisphosphonates induce apoptosis in human breast cancer cell lines
por: Senaratne, S G, et al.
Publicado: (2000)